BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34089292)

  • 1. Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma.
    Wang C; Jing J; Hu X; Yu S; Yao F; Li Z; Cheng L
    J Cell Mol Med; 2021 Jul; 25(13):6232-6241. PubMed ID: 34089292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
    Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
    Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.
    Zhang Y; Liu Z; Yang X; Lu W; Chen Y; Lin Y; Wang J; Lin S; Yun JP
    Theranostics; 2021; 11(3):1473-1492. PubMed ID: 33391546
    [No Abstract]   [Full Text] [Related]  

  • 4. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog/GLI1 signaling pathway regulates the resistance to cisplatin in human osteosarcoma.
    Chen D; Kang X; Li Z; Chen L; Ma Q; Fan P
    J Cancer; 2021; 12(22):6676-6684. PubMed ID: 34659557
    [No Abstract]   [Full Text] [Related]  

  • 6. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity.
    Zhen C; Chen L; Zhao Q; Liang B; Gu YX; Bai ZF; Wang K; Xu X; Han QY; Fang DF; Wang SX; Zhou T; Xia Q; Gong WL; Wang N; Li HY; Jin BF; Man JH
    Oncogene; 2013 Jul; 32(29):3452-60. PubMed ID: 22890318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degalactotigonin, a Natural Compound from
    Zhao Z; Jia Q; Wu MS; Xie X; Wang Y; Song G; Zou CY; Tang Q; Lu J; Huang G; Wang J; Lin DC; Koeffler HP; Yin JQ; Shen J
    Clin Cancer Res; 2018 Jan; 24(1):130-144. PubMed ID: 28951519
    [No Abstract]   [Full Text] [Related]  

  • 8. LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR-516b-5p/Gli1 axis.
    Pan X; Tan J; Tao T; Zhang X; Weng Y; Weng X; Xu J; Li H; Jiang Y; Zhou D; Shen Y
    Cancer Sci; 2021 Jun; 112(6):2260-2271. PubMed ID: 33837611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
    Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
    Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
    Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
    Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
    Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
    Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
    Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
    Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
    Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity.
    Zhang Y; Liu Z; Zhong Z; Ji Y; Guo H; Wang W; Chen C
    J Exp Clin Cancer Res; 2024 Feb; 43(1):52. PubMed ID: 38383479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.
    Zeng YC; Sun D; Li WH; Zhao J; Xin Y
    Tumour Biol; 2017 Jun; 39(6):1010428317704820. PubMed ID: 28653901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin.
    Xu X; Lou Y; Tang J; Teng Y; Zhang Z; Yin Y; Zhuo H; Tan Z
    Cell Death Dis; 2019 Jan; 10(2):86. PubMed ID: 30692513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.
    Li M; Guo T; Lin J; Huang X; Ke Q; Wu Y; Fang C; Hu C
    J Ethnopharmacol; 2022 Jan; 283():114689. PubMed ID: 34592340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance.
    Peng G; Wang C; Wang H; Qu M; Dong K; Yu Y; Jiang Y; Gan S; Gao X
    Oncoimmunology; 2023; 12(1):2173422. PubMed ID: 36776524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.
    Song X; Wang J; Zheng T; Song R; Liang Y; Bhatta N; Yin D; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2013 Oct; 12(1):114. PubMed ID: 24093956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.